Andrew Jackson - Chief Financial Officer at Calidi Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
CLDI on NYSE, CLDWW on OTC
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew Jackson since 10 Jan 2025

Holdings reported by Andrew Jackson for Calidi Biotherapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2,500 $1,475 $0.5900 21 Aug 2025 Direct
Stock Options (right to buy) 30,000 03 Sep 2025 Direct Common stock
Warrant (right to buy) 2,500 21 Aug 2025 Direct Common stock

Transactions reported by Andrew Jackson for Calidi Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.